Guggenheim Initiates Coverage On 1Life Healthcare with Neutral Rating
Guggenheim analyst Sandy Draper initiates coverage on 1Life Healthcare (NASDAQ:ONEM) with a Neutral rating.
Deutsche Bank Maintains Buy on 1Life Healthcare, Lowers Price Target to $16
Deutsche Bank analyst George Hill maintains 1Life Healthcare (NASDAQ:ONEM) with a Buy and lowers the price target from $18 to $16.
Piper Sandler Maintains Overweight on 1Life Healthcare, Lowers Price Target to $20
Piper Sandler analyst Sean Wieland maintains 1Life Healthcare (NASDAQ:ONEM) with a Overweight and lowers the price target from $37 to $20.
SVB Leerink Maintains Market Perform on 1Life Healthcare, Lowers Price Target to $10
SVB Leerink analyst Whit Mayo maintains 1Life Healthcare (NASDAQ:ONEM) with a Market Perform and lowers the price target from $24 to $10.
Keybanc Maintains Overweight on 1Life Healthcare, Lowers Price Target to $14
Keybanc analyst Donald Hooker maintains 1Life Healthcare (NASDAQ:ONEM) with a Overweight and lowers the price target from $30 to $14.
1Life Healthcare Q4 EPS $(0.50) Beats $(0.53) Estimate, Sales $230.21M Beat $218.87M Estimate
1Life Healthcare (NASDAQ:ONEM) reported quarterly losses of $(0.50) per share which beat the analyst consensus estimate of $(0.53) by 5.66 percent. This is a 733.33 percent decrease over losses of $(0.06) per share from
1Life Healthcare: Q4 Earnings Insights
1Life Healthcare (NASDAQ:ONEM) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings Scheduled For February 23, 2022
Companies Reporting Before The Bell
• Sapiens Intl Corp (NASDAQ:SPNS) is likely to report earnings for its fourth quarter.
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 445 companies made new 52-week lows.
JP Morgan Maintains Overweight on 1Life Healthcare, Lowers Price Target to $28
JP Morgan analyst Lisa Gill maintains 1Life Healthcare (NASDAQ:ONEM) with a Overweight and lowers the price target from $41 to $28.